新里程：旗下医院暂未开展质子治疗业务

Core Viewpoint - The company has not yet launched proton therapy services in its hospitals but is actively monitoring advancements in medical technology for future implementation based on regional demand and strategic alignment [2]. Group 1 - The company responded to an investor inquiry regarding its technological advantages in proton therapy [2]. - The company emphasizes its commitment to exploring cutting-edge medical technologies for clinical application in its hospitals [2]. - Future exploration of proton therapy will depend on factors such as regional medical needs and the maturity of the technology [2].